Long Term Study of 'Immuncell-LC Groups' and 'Non-treatment Groups' in Patient Undergo Curative Resection (PEIT, Radiofrequency Ablation [RFA] or Operation) for Hepatocellular Carcinoma in Korea.
Phase of Trial: Phase IV
Latest Information Update: 14 Apr 2018
At a glance
- Drugs T-lymphocyte cell therapy (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Green Cross Cell
- 14 Apr 2018 Results of an extended 5-year follow up assessing efficacy presented at The International Liver Congress 2018
- 04 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.